94 related articles for article (PubMed ID: 30711624)
1. α-Methyl-prednisolone normalizes the PKC mediated brain angiogenesis in dystrophic mdx mice.
Annese T; Ruggieri S; De Giorgis M; Ribatti D; Tamma R; Nico B
Brain Res Bull; 2019 Apr; 147():69-77. PubMed ID: 30711624
[TBL] [Abstract][Full Text] [Related]
2. HIF activation and VEGF overexpression are coupled with ZO-1 up-phosphorylation in the brain of dystrophic mdx mouse.
Nico B; Mangieri D; Crivellato E; Longo V; De Giorgis M; Capobianco C; Corsi P; Benagiano V; Roncali L; Ribatti D
Brain Pathol; 2007 Oct; 17(4):399-406. PubMed ID: 17784876
[TBL] [Abstract][Full Text] [Related]
3. Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx mice.
Tamma R; Annese T; Capogrosso RF; Cozzoli A; Benagiano V; Sblendorio V; Ruggieri S; Crivellato E; Specchia G; Ribatti D; De Luca A; Nico B
Lab Invest; 2013 May; 93(5):592-610. PubMed ID: 23528847
[TBL] [Abstract][Full Text] [Related]
4. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.
Nico B; Frigeri A; Nicchia GP; Corsi P; Ribatti D; Quondamatteo F; Herken R; Girolamo F; Marzullo A; Svelto M; Roncali L
Glia; 2003 May; 42(3):235-51. PubMed ID: 12673830
[TBL] [Abstract][Full Text] [Related]
5. Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.
Capogrosso RF; Cozzoli A; Mantuano P; Camerino GM; Massari AM; Sblendorio VT; De Bellis M; Tamma R; Giustino A; Nico B; Montagnani M; De Luca A
Pharmacol Res; 2016 Apr; 106():101-113. PubMed ID: 26930420
[TBL] [Abstract][Full Text] [Related]
6. Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse.
Nico B; Corsi P; Ria R; Crivellato E; Vacca A; Roccaro AM; Mangieri D; Ribatti D; Roncali L
Neuroscience; 2006 Jul; 140(3):835-48. PubMed ID: 16650610
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy.
Cozzoli A; Rolland JF; Capogrosso RF; Sblendorio VT; Longo V; Simonetti S; Nico B; De Luca A
Neuropathol Appl Neurobiol; 2011 Apr; 37(3):243-56. PubMed ID: 20618838
[TBL] [Abstract][Full Text] [Related]
8. Nerve growth factor and its receptors TrkA and p75 are upregulated in the brain of mdx dystrophic mouse.
Nico B; Mangieri D; De Luca A; Corsi P; Benagiano V; Tamma R; Annese T; Longo V; Crivellato E; Ribatti D
Neuroscience; 2009 Jul; 161(4):1057-66. PubMed ID: 19376199
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
10. Photobiomodulation Therapy for Attenuating the Dystrophic Phenotype of Mdx Mice.
Macedo AB; Mizobuti DS; Hermes TA; Mâncio RD; Pertille A; Kido LA; Cagnon VHA; Minatel E
Photochem Photobiol; 2020 Jan; 96(1):200-207. PubMed ID: 31733143
[TBL] [Abstract][Full Text] [Related]
11. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
12. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier alterations in MDX mouse, an animal model of the Duchenne muscular dystrophy.
Nico B; Roncali L; Mangieri D; Ribatti D
Curr Neurovasc Res; 2005 Jan; 2(1):47-54. PubMed ID: 16181099
[TBL] [Abstract][Full Text] [Related]
15. A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy.
Nico B; Marzullo A; Corsi P; Vacca A; Roncali L; Ribatti D
Neuroscience; 2004; 123(3):585-8. PubMed ID: 14706770
[TBL] [Abstract][Full Text] [Related]
16. Implications of increased S100β and Tau5 proteins in dystrophic nerves of two mdx mouse models for Duchenne muscular dystrophy.
Krishnan VS; Aartsma-Rus A; Overzier M; Lutz C; Bogdanik L; Grounds MD
Mol Cell Neurosci; 2020 Jun; 105():103484. PubMed ID: 32240725
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 expression in mdx mouse brain.
Nico B; Corsi P; Vacca A; Roncali L; Ribatti D
Brain Res; 2002 Oct; 953(1-2):12-6. PubMed ID: 12384233
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
[TBL] [Abstract][Full Text] [Related]
19. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
Guo Y; Petrof BJ; Hussain SN
Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
[TBL] [Abstract][Full Text] [Related]
20. Motor performance of young dystrophic mdx mice treated with long-circulating prednisolone liposomes.
Weller C; Zschüntzsch J; Makosch G; Metselaar JM; Klinker F; Klinge L; Liebetanz D; Schmidt J
J Neurosci Res; 2012 May; 90(5):1067-77. PubMed ID: 22253213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
